Ernexa Therapeutics (ERNA) Profit After Tax (2016 - 2025)
Historic Profit After Tax for Ernexa Therapeutics (ERNA) over the last 16 years, with Q3 2025 value amounting to -$1.2 million.
- Ernexa Therapeutics' Profit After Tax rose 9533.9% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$18.3 million, marking a year-over-year increase of 5918.37%. This contributed to the annual value of -$44.5 million for FY2024, which is 10555.2% down from last year.
- Ernexa Therapeutics' Profit After Tax amounted to -$1.2 million in Q3 2025, which was up 9533.9% from -$3.1 million recorded in Q2 2025.
- Over the past 5 years, Ernexa Therapeutics' Profit After Tax peaked at -$1.2 million during Q3 2025, and registered a low of -$86.0 million during Q3 2021.
- For the 5-year period, Ernexa Therapeutics' Profit After Tax averaged around -$12.2 million, with its median value being -$5.8 million (2024).
- Its Profit After Tax has fluctuated over the past 5 years, first tumbled by 570594.19% in 2021, then soared by 9533.9% in 2025.
- Ernexa Therapeutics' Profit After Tax (Quarter) stood at -$86.0 million in 2021, then surged by 94.78% to -$4.5 million in 2022, then tumbled by 37.07% to -$6.2 million in 2023, then increased by 6.4% to -$5.8 million in 2024, then soared by 78.47% to -$1.2 million in 2025.
- Its last three reported values are -$1.2 million in Q3 2025, -$3.1 million for Q2 2025, and -$8.2 million during Q1 2025.